Ketamine, Esketamine and Depression

In October 2019, the U.S. Food and Drug Administration (FDA) approved esketamine, a substance chemicallyrelated to the party drug ketamine, as a nasal spray to treat depression (Bahr, 2019). The effectiveness of ketamine for depression was first shown in studies in...

Complementary and Alternative Treatments for Dementia

Over the past few decades, there has been a growing number of herbal remedies, dietary supplements and other therapies promoted as treatments to delay or prevent various forms of dementia. As the claims about the safety and effectiveness of these products grow, so...